Therefore, it might be concluded that neutrophils experience a different apoptosis response over time and in comparison with other cell types of the SB525334 respiratory compartment. In a first phase of acute injury, a delay in apoptosis would provide neutrophils with a longer life-span, possibly inducing or aggravating

injury as described in patients with sepsis and sepsis-induced ARDS [22]. In a later phase concerning resolution of an injury, apoptosis rate increases. Under hypoxic conditions, apoptosis rate of epithelial cells and alveolar macrophages did not change. Neutrophils, however, again experienced a different reaction regarding apoptosis rate compared to the other cell types. Hypoxia decreased caspase-3 activity in neutrophils after 4 h of exposure, while at time-points of 8 and 24 h caspase-3 activity was increased. Current data indicate that many factors operating at the inflamed site such as hypoxia and acidosis serve a dual function in both priming

and activating neutrophils by delaying apoptosis as well as decreased accumulation and function by increasing apoptosis [23]. As observed for alveolar epithelial cells, activation pathway of apoptosis is not clear in neutrophils. learn more In conclusion, our data show that the three cell types from the respiratory compartment alveolar and trachebronchial epithelial cells as well as alveolar macrophages show the same pattern of apoptosis regarding caspase-3 activity upon exposure to endotoxin and hypoxia. The apoptotic answer of neutrophils, however, is different. The functional implications of these inflammatory answers need to be analysed further. This study was supported by the Olga Mayenfisch Stiftung, Zurich, Switzerland and the Jubiläumsstiftung der Schweizerischen Lebensversicherungs-

MRIP und Rentenanstalt, Zurich, Switzerland. None. “
“IL-10-producing CD4+ type 1 regulatory T (Tr1) cells, defined based on their ability to produce high levels of IL-10 in the absence of IL-4, are major players in the induction and maintenance of peripheral tolerance. Tr1 cells inhibit T-cell responses mainly via cytokine-dependent mechanisms. The cellular and molecular mechanisms underlying the suppression of APC by Tr1 cells are still not completely elucidated. Here, we defined that Tr1 cells specifically lyse myeloid APC through a granzyme B (GZB)- and perforin (PRF)-dependent mechanism that requires HLA class I recognition, CD54/lymphocyte function-associated antigen (LFA)-1 adhesion, and activation via killer cell Ig-like receptors (KIRs) and CD2. Notably, interaction between CD226 on Tr1 cells and their ligands on myeloid cells, leading to Tr1-cell activation, is necessary for defining Tr1-cell target specificity. We also showed that high frequency of GZB-expressing CD4+ T cells is detected in tolerant patients and correlates with elevated occurrence of IL-10-producing CD4+ T cells.